Efficacy of Triple Therapy of Vonoprazan, Amoxicillin, and Sitafloxacin as the Third-Line Regimen for Helicobacter pylori Eradication in Japan

被引:0
|
作者
Shimoyama, Tadashi [1 ]
Higuchi, Naoki [2 ]
Oyama, Takao [1 ]
Higuchi, Hiroyuki [3 ]
Chinda, Daisuke [4 ]
Fukuda, Shinsaku [1 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan
[2] Hirosaki Natl Hosp, Hirosaki, Aomori, Japan
[3] Hirosaki Univ, Grad Sch Med, Hachinohe, Aomori, Japan
[4] Hirosaki Univ, Grad Sch Med, Dept Gastroenterol, Hirosaki, Aomori, Japan
来源
关键词
D O I
10.14309/00000434-201610001-01144
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1144
引用
收藏
页码:S498 / S498
页数:1
相关论文
共 50 条
  • [31] Gatifloxacin based triple therapy in third-line H pylori eradication regimen:: A randomized controlled trial
    Nishizawa, Toshihiro
    Suzuki, Hidekazu
    Takahashi, Ayako
    Masaoka, Tatsuhiro
    Murooka, Hiroe
    Takahashi, Tetsufumi
    Iwasaki, Eisuke
    Kobayashi, Intetsu
    Hibi, Toshifumi
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S86 - S87
  • [32] Current Status of the Third-Line Helicobacter pylori Eradication
    Choi, Jae Ho
    Yang, Young Joo
    Bang, Chang Seok
    Lee, Jae Jun
    Baik, Gwang Ho
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [33] Efficacy of Vonoprazan for Helicobacter pylori Eradication
    Kiyotoki, Shu
    Nishikawa, Jun
    Sakaida, Isao
    [J]. INTERNAL MEDICINE, 2020, 59 (02) : 153 - 161
  • [34] Levofloxacin based triple therapy for third line Helicobacter pylori eradication
    Lee, M.
    Kim, G.
    Lee, B.
    Song, G.
    Park, S.
    Park, S.
    Park, J.
    Kim, S.
    [J]. HELICOBACTER, 2018, 23
  • [35] Second-line triple therapy in failures with vonoprazan-based triple therapy for eradication of Helicobacter pylori
    Mori, Naoyoshi
    Nishiura, Yuuki
    Suga, Daisuke
    Moritani, Isao
    Yamanaka, Yutaka
    Ooya, Yumi
    Inoue, Hidekazu
    Takase, Koujirou
    Hioki, Masato
    Shiraki, Katsuya
    [J]. BIOMEDICAL REPORTS, 2018, 9 (02) : 169 - 174
  • [36] A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication
    Zullo, A
    Hassan, C
    De Francesco, V
    Lorenzetti, R
    Marignani, M
    Angeletti, S
    Ierardi, E
    Morini, S
    [J]. DIGESTIVE AND LIVER DISEASE, 2003, 35 (04) : 232 - 236
  • [37] Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan
    Kazunari Murakami
    Takahisa Furuta
    Takashi Ando
    Takeshi Nakajima
    Yoshikatsu Inui
    Tadayuki Oshima
    Toshihiko Tomita
    Katsuhiro Mabe
    Makoto Sasaki
    Takanori Suganuma
    Hideyuki Nomura
    Kiichi Satoh
    Shinichiro Hori
    Syuuji Inoue
    Takeshi Tomokane
    Mineo Kudo
    Tomoki Inaba
    Susumu Take
    Toshifumi Ohkusa
    Shojiro Yamamoto
    Shigeaki Mizuno
    Toshiro Kamoshida
    Kenji Amagai
    Junichi Iwamoto
    Jun Miwa
    Masaaki Kodama
    Tadayoshi Okimoto
    Mototsugu Kato
    Masahiro Asaka
    [J]. Journal of Gastroenterology, 2013, 48 : 1128 - 1135
  • [38] Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan
    Murakami, Kazunari
    Furuta, Takahisa
    Ando, Takashi
    Nakajima, Takeshi
    Inui, Yoshikatsu
    Oshima, Tadayuki
    Tomita, Toshihiko
    Mabe, Katsuhiro
    Sasaki, Makoto
    Suganuma, Takanori
    Nomura, Hideyuki
    Satoh, Kiichi
    Hori, Shinichiro
    Inoue, Syuuji
    Tomokane, Takeshi
    Kudo, Mineo
    Inaba, Tomoki
    Take, Susumu
    Ohkusa, Toshifumi
    Yamamoto, Shojiro
    Mizuno, Shigeaki
    Kamoshida, Toshiro
    Amagai, Kenji
    Iwamoto, Junichi
    Miwa, Jun
    Kodama, Masaaki
    Okimoto, Tadayoshi
    Kato, Mototsugu
    Asaka, Masahiro
    [J]. JOURNAL OF GASTROENTEROLOGY, 2013, 48 (10) : 1128 - 1135
  • [39] Helicobacter pylori eradication rate of levofloxacin-based therapy as third-line therapy
    Kang, M.
    Lee, S.
    Goo, E.
    Kim, K.
    Jang, B.
    Yang, C.
    [J]. HELICOBACTER, 2017, 22
  • [40] Efficacy of levofloxacin-based third-line therapy for the eradication of Helicobacter pylori in central Seoul, Korea
    Moon, J.
    Lee, D.
    Shin, Y.
    Lee, S.
    Park, T.
    Ryu, S.
    Kim, Y.
    Seol, S.
    [J]. HELICOBACTER, 2019, 24